Centogene Story

CNTG -- USA Stock

USD 12.08 0.21 1.77%

Macroaxis Story

Centogene Capital Expenditure is projected to increase significantly based on the last few years of reporting. The past year's Capital Expenditure was at 21 Million. The current year Net Cash Flow or Change in Cash and Cash Equivalents is expected to grow to about 34.4 M, whereas Earnings before Tax are forecasted to decline to (21 M). Centogene NV is scheduled to announce its earnings today. The next earnings report is expected on the 3rd of December 2020. The stock experiences an active downward rally. Many investors are getting excited about healthcare space, let's analyze if Centogene NV fundamentals are strong enough to attract traders. What exactly are Centogene shareholders getting in October? The company current probability of distress is under 15 percent. Will shareholders continue to be optimistic, or should we expect a sell-off?

Published over a month ago

View all stories for Centogene | View All Stories

Are Centogene (NASDAQ:CNTG) unsteady basic indicators contributing to the latest dip?

The firm shows a Beta (market volatility) of -0.6756, which signifies possible diversification benefits within a given portfolio. Let's try to break down what Centogene's beta means in this case. As returns on the market increase, returns on owning Centogene are expected to decrease at a much lower rate. During the bear market, Centogene is likely to outperform the market. Even though it is essential to pay attention to Centogene NV historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Centogene NV exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Centogene NV has an expected return of -0.94%. Please be advised to confirm Centogene NV sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change to decide if Centogene NV stock performance from the past will be repeated at some point in the near future.

Typically, a company's financial statements are the reports that show the financial position of the company. There are three main documents that fall into the category of financial statements. These documents include Centogene income statement, its balance sheet, and the statement of cash flows. Potential Centogene investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Centogene investors may use each financial statement separately, they are all related. The changes in Centogene's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Centogene's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages. The goal of Centogene fundamental analysis is to do accurate financial forecasts. There are several possible objectives to fundamental analysis, such as projecting of Centogene performance into the future periods or doing a reasonable stock valuation. The intrinsic value of Centogene shares is the value that is considered the true value of the share. If the intrinsic value Centogene is higher than its market price, buying is generally recommended. If it is equal to the market price, it is recommended to hold; and if it is less than the market price, then one should sell all shares Centogene. Please read more on our fundamental analysis page.

Are Centogene Earnings Expected to grow?

The future earnings power of Centogene involves the interaction of many company-specific, industry, and economic forces. Earnings estimates embody investors' opinions of Centogene factors such as sales growth, product demand, competitive industry environment, profit margins, and cost controls. Centogene stock prices adjust as these expectations change or are proven wrong. The main thing to remember is that equities with high expected earnings growth tend to underperform the market because it is usually difficult to meet the market's high expectations. Companies with low earnings expectations tend to do better than expected. Please use our latest analysis of Centogene expected earnings.

How Centogene utilizes its cash?

To perform a cash flow analysis of Centogene, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Centogene is receiving and how much cash it distributes out in a given period. The Centogene cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Centogene Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at (7.78 Million)

Centogene Gross Profit

Centogene Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Centogene previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Centogene Gross Profit growth over the last 10 years. Please check Gross Profit in more details.

A Deeper look at Centogene

Although in the United States, the Securities and Exchange Commission has enforced strong rules to prevent insiders from engaging in insider trading, finding insiders among active shareholders of Centogene is not uncomon. Institutional investors typically avoid acquiring a high percentage of Centogene stocks because performing such an act may violate securities laws. They are usually not investing their own money, but rather making investments on behalf of their clients. Let's take a look at how the ownership of Centogene is distributed among investors.

Ownership Allocation

Centogene NV retains a total of 21.86 Million outstanding shares. Centogene NV retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Retail Investors

47.88%

Insiders

28.45%

Institutions

23.67%

	Retail Investors	47.88
	Insiders	28.45
	Institutions	23.67

Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Centogene has an asset utilization ratio of 42.88 percent. This indicates that the company is making $0.43 for each dollar of assets. An increasing asset utilization means that Centogene NV is more efficient with each dollar of assets it utilizes for everyday operations.

Current Assets

57.1 M

Assets Non Current

52.9 M

Current Assets	57.14 Million	46.32
Assets Non Current	52.89 Million	42.88
Goodwill	13.32 Million	10.8

Will Centogene continue to go ballistic?

The market risk adjusted performance is down to 1.22 as of today. Centogene NV exhibits very low volatility with skewness of -1.12 and kurtosis of 4.49. However, we advise investors to further study Centogene NV technical indicators to make sure all market info is available and is reliable.

Our Takeaway on Centogene Investment

Although some other companies in the diagnostics & research industry are either recovering or due for a correction, Centogene may not be performing as strong as the other in terms of long-term growth potentials. The inconsistency in the assessment between current Centogene valuation and our trade advice on Centogene is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Centogene.

About Contributor

Raphi Shpitalnik is a Junior Member of Macroaxs Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time base at the beginning of the pandemic and eventually acquired a real test for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Centogene NV. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2020 Macroaxis LLC